Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2013
02/21/2013US20130045975 Bicyclic heteroaryl inhibitors of pde4
02/21/2013US20130045974 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
02/21/2013US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
02/21/2013US20130045965 Inhibitors of bruton's tyrosine kinase
02/21/2013US20130045964 Mandelamide heterocyclic compounds
02/21/2013US20130045962 Peptide deformylase inhibitors
02/21/2013US20130045955 Novel compounds
02/21/2013US20130045939 Fatty acid macrolide derivatives and their uses
02/21/2013US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
02/21/2013US20130045898 Polyester amide foamers
02/21/2013CA2845284A1 Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors
02/21/2013CA2844982A1 Lysophosphatidic acid receptor antagonists
02/21/2013CA2844794A1 Heterocyclic derivative and pharmaceutical
02/21/2013CA2843499A1 Indazole compounds, compositions and methods of use
02/21/2013CA2841012A1 Sweet flavor modifier
02/20/2013EP2559690A1 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
02/20/2013EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors
02/20/2013EP2558457A1 Arylethynyl derivatives
02/20/2013EP2558452A2 Oxazole and thiazole compounds as ksp inhibitors
02/20/2013EP2558449A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
02/20/2013CN102939288A Process for the preparation of dihydropyrrole derivatives
02/19/2013US8378118 Pyrazole-based thyroid receptor compounds
02/19/2013US8378108 Apoptosis signal-regulating kinase inhibitors
02/19/2013US8378096 Hexahydro-cycloheptapyrazole cannabinoid modulators
02/19/2013US8378095 Oxazole tyrosine kinase inhibitors
02/19/2013US8377942 Isoxazolines derivatives and their use as pesticide
02/19/2013US8377940 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842
02/19/2013US8377939 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842
02/19/2013US8377932 Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2(1H)pyridone compounds and salts thereof and their applications
02/19/2013US8377931 Benzoxazine derivatives and uses thereof
02/19/2013US8377924 Protein kinase C inhibitors and uses thereof
02/19/2013CA2703257C Benzomorpholine derivatives and methods of use
02/19/2013CA2573371C Pyrimidines as plk inhibitors
02/19/2013CA2562780C Nucleic acid melting analysis with saturation dyes
02/19/2013CA2557054C (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
02/19/2013CA2508657C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
02/19/2013CA2486187C Kinase inhibitors
02/14/2013WO2013021363A1 Quinazoline-2,4-dione derivatives
02/14/2013WO2013021344A1 Imidazole derivatives as antiviral agents
02/14/2013WO2013021315A1 Process for the preparation of benzohetero [ 1, 3 ] - diazole compounds disubstituted with heteoaryl groups
02/14/2013WO2013021044A1 1,2,4-triazolyl-substituted keto-enols
02/14/2013WO2013020993A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
02/14/2013US20130041046 Sweet flavor modifier
02/14/2013US20130041008 Compounds for enzyme inhibition
02/14/2013US20130040977 Pro-Neurogenic Compounds
02/14/2013US20130040962 P38 MAP Kinase Inhibitors
02/14/2013US20130040950 Multisubstituted aromatic compounds as inhibitors of thrombin
02/14/2013US20130040949 Type ii raf kinase inhibitors
02/14/2013US20130040948 Novel benzodioxole piperazine compounds
02/14/2013US20130040947 Trkb agonists and methods of use
02/14/2013US20130040945 Certain chemical entities, compositions, and methods
02/14/2013US20130040944 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
02/14/2013US20130040941 Benzodiazepine compound and pharmaceutical composition
02/14/2013US20130040936 1,4-oxazepines as bace1 and/or bace2 inhibitors
02/14/2013US20130040931 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use
02/14/2013US20130040930 Novel amide derivative and use thereof as medicine
02/14/2013US20130040929 Novel prolylcarboxypeptidase inhibitors
02/14/2013US20130040912 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
02/14/2013US20130039944 Anti-Viral Compounds
02/14/2013CA2855948A1 1,2,4-triazolyl-substituted keto-enols
02/14/2013CA2844440A1 Process for the preparation of benzohetero[1,3]diazole compounds disubstituted with heteroaryl groups
02/14/2013CA2842885A1 Quinazoline-2,4-dione derivatives
02/14/2013CA2842123A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
02/13/2013EP2556071A1 Kinase inhibitors and method of treating cancer with same
02/13/2013EP2556070A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
02/13/2013EP2556056A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
02/13/2013EP2555772A1 Oxazole derivatives useful as modulators of faah
02/13/2013CN102933577A Fungicidal oximes and hydrazones
02/13/2013CN102933575A Yclohexyl-azetidinyl antagonists of ccr2
02/13/2013CN102933564A 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
02/13/2013CN102925136A Zn<2+> ratiometric fluorescent probe compound and preparation method and use thereof
02/13/2013CN102924445A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy
02/13/2013CN102924440A Preparation and synthesis method of chiral oxazoline
02/13/2013CN102924439A Preparation method of iloperidone
02/13/2013CN102920695A Benzofuran endothelin receptor antagonist and use
02/13/2013CN102070626B New method for preparing iloperidone
02/13/2013CN101952260B 4, 5-dihydro-oxazol-2-yl amine derivatives
02/13/2013CN101868457B (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
02/13/2013CN101808999B Quinoline derivatives as 5HT5A receptor antagonists
02/13/2013CN101490035B Amino-piperidine derivatives as CETP inhibitors
02/12/2013US8372984 Dual-acting oxazole antihypertensive agents
02/12/2013US8372981 Nitrogen-containing aromatic derivatives
02/12/2013US8372980 Fused ring thrombin receptor antagonists
02/12/2013US8372978 Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
02/12/2013US8372971 Heterocyclic compounds and methods of use
02/12/2013US8372970 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
02/12/2013US8372867 Insecticidal aryl isoxazoline derivatives
02/12/2013US8372823 Tetracyclic inhibitors of fatty acid amide hydrolase
02/12/2013CA2628750C 4-oxadiazolyl-piperidine compounds and use thereof
02/12/2013CA2596527C Igf-1r inhibitors
02/12/2013CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors
02/07/2013WO2013019561A1 Nuclear transport modulators and uses thereof
02/07/2013WO2013018899A1 Dibenzooxepin derivative
02/07/2013WO2013018804A1 Uracil derivative and use thereof for medical purposes
02/07/2013WO2013018675A1 N-hetero-ring-substituted amide derivative
02/07/2013WO2013017657A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
02/07/2013WO2013017071A1 Alicyclic[c] benzopyrone derivatives and uses thereof
02/07/2013WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use
02/07/2013US20130035339 Apoptosis signal-regulating kinase inhibitors
02/07/2013US20130035337 Fused bicyclic heteroaryl derivative
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 647